Steady-state Kinetics and Inhibitory Action of Antitubercular Phenothiazines on Mycobacterium tuberculosis Type-II NADH-Menaquinone Oxidoreductase (NDH-2)
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Type-II NADH-menaquinone oxidoreductase (NDH-2) is an essential respiratory enzyme of the pathogenic bacterium Mycobacterium tuberculosis (Mtb) that plays a pivotal role in its growth. In the present study, we expressed and purified highly active Mtb NDH-2 using a Mycobacterium smegmatis expression system, and the steady-state kinetics and inhibitory actions of phenothiazines were characterized. Purified NDH-2 contains a non-covalently bound flavin adenine dinucleotide cofactor and oxidizes NADH with quinones but does not react with either NADPH or oxygen. Ubiquinone-2 (Q2) and decylubiquinone showed high electron-accepting activity, and the steady-state kinetics and the NADH-Q2 oxidoreductase reaction were found to operate by a ping-pong reaction mechanism. Phenothiazine analogues, trifluoperazine, Compound 1, and Compound 2 inhibit the NADH-Q2 reductase activity with IC50 = 12, 11, and 13 microm, respectively. Trifluoperazine inhibition is non-competitive for NADH, whereas the inhibition kinetics is found to be uncompetitive in terms of Q2.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




![FIGURE 5 Hanes plots of the steady-state kinetics of the NADH-Q2 oxidoreductase activity of the purified Mtb NDH-2. Q2 reductase activities at various Q2 concentrations were plotted in a Hanes-Woolf plot ([Q2] versus [Q2]/ v ) and a Lineweaver-Burk plot (1/[Q2] versus 1/ v , inset ). NADH concentrations were varied: 10 𝛍 M ( closed square ), 20 𝛍 M ( open triangle ), 30 𝛍 M ( closed triangle ), 50 𝛍 M ( open circle ), and 100 𝛍 M ( closed circle ).](https://figures.cochat.ai/paper-figures/b925cfb0107748a485452f1156db312d/steady-state-kinetics-and-inhibitory-action-of-antitubercular-phenothiazines-on-figure-5.png)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“NDH-2 has not been reported in mammalian mitochondria leading to the proposal that these enzymes may represent a potential drug target for the treatment of human pathogens (6, 12, 27, 30, 31) and intracellular parasites (32).”
From Energetics of Respiration and Oxidative Phosphorylation in Mycobacteria (2014) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENT
Lowry, O., Rosebrough, N., Farr, A. L., & Randall, R. (1951) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)52451-6 · Cited by 317,331
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Assay of proteins in the presence of interfering materials
Bensadoun, A., & Weinstein, D. (1976) · Analytical Biochemistry · doi:10.1016/s0003-2697(76)80064-4 · Cited by 3,179
Genetic requirements for mycobacterial survival during infection
Sassetti, C. M., & Rubin, E. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2134250100 · Cited by 1,354
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
The Transcriptional Responses of Mycobacterium tuberculosis to Inhibitors of Metabolism
Boshoff, H. I. M., Myers, T. G., Copp, B. R., McNeil, M. R., Wilson, M. A., & Barry, C. E. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406796200 · Cited by 606
Messner, K. R., & Imlay, J. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.15.10119 · Cited by 299
Inhibitors of type II NADH:menaquinone oxidoreductase represent a class of antitubercular drugs
Weinstein, E. A., Yano, T., Li, L.-S., Avarbock, D., Avarbock, A., Helm, D., McColm, A. A., Duncan, K., Lonsdale, J. T., & Rubin, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500469102 · Cited by 289
Self-citationA rapid micromethod for determination of FMN and FAD in mixtures
Faeder, E. J., & Siegel, L. M. (1973) · Analytical Biochemistry · doi:10.1016/0003-2697(73)90442-9 · Cited by 288
Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284
Research works printed but not linked: 2
- Molnar, 1977, Zentralbl Bakteriol [Orig. A], 239, 521
- Kristiansen, 1986, Acta Pathol. Microbiol. Immunol. Scand. B, 94, 393
Cited by
Items 101–153 of 153
An Experimental Model for the Rapid Screening of Compounds with Potential Use Against Mycobacteria
Costa, S. S., Lopes, E., Azzali, E., Machado, D., Coelho, T. S., da Silva, P. E. A., Viveiros, M., Pieroni, M., & Couto, I. (2016) · Assay and Drug Development Technologies · doi:10.1089/adt.2016.752 · Cited by 17
“18,46 In fact, they have been described as inhibitors of the enzyme type-II NADH-menaquinone dehydrogenase, essential in the M. tuberculosis respiratory chain, 47 as inhibitors of calcium–calmodulin binding, 48 and as inhibitors of mycobacterial efflux pumps.”
A novel calcium binding protein in Mycobacterium tuberculosis--potential target for trifluoperazine.
Koul, S., Somayajulu, A., Advani, M. J., & Reddy, H. (2009) · PubMed · Cited by 14
Structure of Mycobacterial NDH-2 Bound to a 2-Mercapto-Quinazolinone Inhibitor
Liang, Y., Bueler, S. A., Cook, G. M., & Rubinstein, J. L. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c00049 · Cited by 13
Potential of Mycobacterium tuberculosis Type II NADH-Dehydrogenase in Antitubercular Drug Discovery
Saha, P., Kumar, M., & Sharma, D. K. (2025) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.4c01005 · Cited by 14
(2008) · Tuberculosis · doi:10.1016/s1472-9792(08)70028-3 · Cited by 16
Tomioka, H. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.3.1.21 · Cited by 13
“Yano T, Li LS, Weinstein E, Teh JS, Rubin H. Steady-state kinetics and inhibitory action of antitubercular phenothiazines on Mycobacterium tuberculosis type-II NADH- menaquinone oxidoreductase (NDH-2).”
BackgroundMethodInfluentialSingh, A., & Sharma, S. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.08.016 · Cited by 11
“tuberculosis [17,18] a key enzyme involved in the metabolic transition of M.”
BackgroundCytochrome bc1-aa3 Oxidase Supercomplex As Emerging and Potential Drug Target Against Tuberculosis
Sindhu, T., & Pal, D. (2021) · Current Molecular Pharmacology · doi:10.2174/1874467214666210928152512 · Cited by 12
Targeting the cytochrome bc1 complex for drug development in M. tuberculosis: review
Wani, M. A., & Dhaked, D. K. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10335-y · Cited by 11
Synthesis of Functionalised Chromonyl‐pyrimidines and Their Potential as Antimycobacterial Agents
Santoso, K. T., Brett, M. W., Cheung, C., Cook, G. M., Stocker, B. L., & Timmer, M. S. M. (2020) · ChemistrySelect · doi:10.1002/slct.202000799 · Cited by 11
Acinetobacter baumannii OxPhos inhibitors as selective anti-infective agents
Rubin, H. N., Selwood, T., Yano, T., Weaver, D. G., Loughran, H. M., Costanzo, M. J., Scott, R. W., Wrobel, J. E., Freeman, K. B., & Reitz, A. B. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.11.020 · Cited by 11
Self-citationFAD binding properties of a cytosolic version of Escherichia coli NADH dehydrogenase-2
Villegas, J. M., Valle, L., Vieyra, F. E. M., Rintoul, M. R., Borsarelli, C. D., & Rapisarda, V. A. (2014) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.12.021 · Cited by 10
Recent Studies on Gramicidin S Analog Structure and Antimicrobial Activity
Pal, S., Ghosh, U., Ampapathi⧧, R. S., & Chakraborty, T. K. (2015) · Topics in heterocyclic chemistry · doi:10.1007/7081_2015_188 · Cited by 10
Bhargavi, G., Hassan, S., Subramanyam, B., Tripathy, S. P., & Palaniyandi, K. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01763-1 · Cited by 10
“tuberculosis adapts to various stress conditions to survive as a successful pathogen inside the host [28].”
BackgroundPłocińska, R., Wasik, K., Płociński, P., Lechowicz, E., Antczak, M., Błaszczyk, E., Dziadek, B. R., Słomka, M., Rumijowska-Galewicz, A., & Dziadek, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.909507 · Cited by 12
“tuberculosis transfers electrons to quinone by NADH dehydrogenases type II (NDH2), which are encoded by ndh and ndhA genes (Yano et al., 2006).”
BackgroundThioridazine for treatment of tuberculosis: Promises and pitfalls
Dutta, N. K., & Karakousis, P. C. (2014) · Tuberculosis · doi:10.1016/j.tube.2014.09.001 · Cited by 10
“TRZ appears to act on enzymes involved in fatty acid metabolism, efflux proteins (emrE-encoded), oxido-reductases, and proteins (ndh-encoded) involved in aerobic respiration, which overlapwith the targets of conventional anti-TB drugs [30,33,34].”
BackgroundNanoDSF Screening for Anti-tubulin Agents Uncovers New Structure–Activity Insights
Baksheeva, V. E., Rocca, R. L., Allegro, D., Soubéran, A., Pasquier, E., Allegro, D., Morelli, X., Pasquier, E., Roche, P., Morelli, X., et al. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c01008 · Cited by 8
Deng, S., Beatty, W. L., & Sibley, L. D. (2025) · mBio · doi:10.1128/mbio.01120-25 · Cited by 9
Rosário, A. L., Sena, F. V., Batista, A. P., Oliveira, T. F., Athayde, D., Pereira, M. M., Brito, J. A., & Archer, M. (2015) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x15005178 · Cited by 7
“…against Plasmodium falciparum (Fisher et al., 2007; Dong et al., 2009; Biagini et al., 2012), the agent that causes malaria, and ISSN 2053-230X # 2015 International Union of Crystallography Mycobacterium tuberculosis (Yano et al., 2006; Teh et al., 2007), the agent that causes tuberculosis.”
BackgroundKumar, S., Koehn, J. T., Juarrero, M. G., Crans, D. C., & Crick, D. C. (2020) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.0c00312 · Cited by 8
Bonefont, L. E., Davenport, H., Chaton, C. T., Korotkov, K. V., & Rohde, K. H. (2024) · Molecular Microbiology · doi:10.1111/mmi.15314 · Cited by 5
Recent advances in inhibitor development and metabolic targeting in tuberculosis therapy
Patel, R. R., Vidyasagar, Singh, S. K., & Singh, M. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107515 · Cited by 6
Sorescu, J. M., González-Montalvo, M. A., Yuan, M., DePaolo-Boisvert, J., Ceapă, C. D., García‐Contreras, R., Flores-Herrera, Ó., Shea, M. E., Tuz, K., & Juárez, O. X. (2025) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2025.2545785 · Cited by 7
“Mycobacterial NDH-2 can be effectively inhibited using phenothiazines such as chlorpromazine and trifluoperazine (Amaral et al. 2001; weinstein et al. 2005; Yano et al. 2006) (Figure 2D).”
Pal, S., Ghosh, U., Singh, G. P., Alam, F., Singh, S. P., Chopra, S., Sinha, S. K., Ampapathi⧧, R. S., & Chakraborty, T. K. (2017) · Asian Journal of Organic Chemistry · doi:10.1002/ajoc.201700183 · Cited by 5
Saha, P., Kumar, M., & Sharma, D. K. (2026) · RSC Medicinal Chemistry · doi:10.1039/d5md00950b · Cited by 4
Amaral, L., Martins, A., Spengler, G., Hunyadi, A., & Molnar, J. A. (2014) · Recent Patents on Anti-Infective Drug Discovery · doi:10.2174/1574891x08666131210141521 · Cited by 5
Lee, J. H., Kyung, S. M., Lee, E., Xiang, X., Park, H.-E., Shin, M.-K., & Yoo, H. S. (2026) · BMC Microbiology · doi:10.1186/s12866-026-04743-z · Cited by 2
“Although mdh may not be strictly essential for survival, its involvement in growth regulation and energy metabolism is supported by findings from studies on other mycobacterial species [23, 53].”
Encoded metabolic remodeling amplifies drug resistance in Mycobacterium tuberculosis
Frey, A. M., Babunovic, G. H., Culviner, P. H., Wang, X., Meirav, E., Gan, M., Zhu, J., Moody, D. B., Liu, Q., & Fortune, S. M. (2026) · PLoS Pathogens · doi:10.1371/journal.ppat.1014237 · Cited by 2
“Since menaquinone and NAD redox are coupled by NADH dehydrogenase activity [26,30,31], we then used a fluorescence assay to measure NAD + and NADH concentrations and found that the ratio of NAD + to NADH similarly trended down in both idsA2 mutant strains (Figs 4D and S11).”
Energy Pathways in Mycobacterium Tuberculosis
Ganeshpurkar, A., Singh, R. P., Singh, M., Kumar, A., & Singh, S. K. (2023) · Integrated science · doi:10.1007/978-3-031-15955-8_25 · Cited by 2
Reversed electron transport in syntrophic degradation of glucose, butyrate and ethanol
Müller, N. (2010) · KOPS (University of Konstanz) · Cited by 3
Makafe, G. G., Cole, L., Roberts, A., Muncil, S. E., Patwardhan, A., Bernacki, D. T., Chojnacki, M., Weinrick, B. C., & Sheinerman, F. B. (2023) · Tuberculosis · doi:10.1016/j.tube.2023.102317 · Cited by 1
Shiraz, M., Biswas, D., Priyanka, G., Prabhu, N. P., & Akif, M. (2025) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.70095 · Cited by 2
“Mtb NDH-II oxidoreductase has been designated as essential for the growth and reported as a possible drug target [5, 6].”
Inhibitors of Type II NADH Dehydrogenase Enzyme: A Review
Sun, G., Shi, Q., Song, Y., Tang, L., Li, S., Yang, T., Hu, K., Ma, L., Shi, X., & Hu, J. (2025) · Current Protein and Peptide Science · doi:10.2174/0113892037350396250213115109 · Cited by 1
Respiratory ATP synthesis as drug target for combating tuberculosis
Haagsma, A. C. (2012) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 1
Hctor, R. (2012) · InTech eBooks · doi:10.5772/30422
“Ndh-2 is the only NADH dehydrogenase enzyme expressed in this pathogen, importantly it is absent in humans that rely on the type 1 Ndh enzyme.”
Cynamon, M. H., & Welch, J. T. (2012) · Advances in microbial ecology · doi:10.1007/978-1-4614-2182-5_6
Serra, C. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
The fitness costs of drug resistance mutations in Mycobacteria
Koch, A. S. (2012) · University of the Witwatersrand, Johannesburg Institutional Repository on DSpace (University of the Witwatersrand, Johannesburg)
Exploring Structural /functional relashionship in Type II NADH: quinone oxidoreductases
Sena, F. V. (2020) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Saharan, V. D., Vijayaraghavan, S., & Mahajan, S. (2015) · INDIAN DRUGS · doi:10.53879/id.52.12.10470
Lee, B. S. (2021) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/155550 · Cited by 1
Structure and regulation of the mycobacterial F1-ATPase
Wong, C. F. (2022) · DR-NTU (Nanyang Technological University) · doi:10.32657/10356/163190
The evolution and mechanistic versatility of the bacterial NADH dehydrogenases type II
Masone, D., van Es, L., Yang, G., Roggero, C. M., Fraaije, M. W., & Mascotti, M. L. (2026) · FEBS Journal · doi:10.1111/febs.70697
Serrano, A. R., Markham, S. A., Dolan, C. C., Arhouma, Z., Whitcomb, L. A., Schlink, D. M., Rose, L., Kostenkova, K., Jankowska, E., Davenport, A., et al. (2026) · Discover Bacteria. · doi:10.1007/s44351-026-00045-x
Gerasimova, T. (2023) · theses.fr (ABES) · doi:10.70675/4166eff1z36b4z4e07za265z8479b7322c10
Sau, S., Agnivesh, P. K., Roy, A., Kumar, S., & Kalia, N. P. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-04936-0
“Yano et al. have demonstrated that clofazimine (CFZ), a clinically prescribed medication for leprosy for a long time, is a redox-active prodrug (derived from phenazine) that is activated by NDH-2 (Yano et al. 2006, 2014, 2011).”
Exploiting NDH-2 Vulnerability: Quinolines as Antitubercular AgentsPreprint
Sau, S., Kumar, R., Roy, A., Agnivesh, P. K., Saha, P., Bhalerao, H. A., Sonti, R., Sharma, D. K., & Kalia, N. P. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.08.730781
Datta, P., Provvedi, R., Sohaskey, C. D., Ukey, R., Puffal, J., Prithviraj, M., Tellez, A. V., Saleh, A. M., Khan, R., Manganelli, R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.09.750162
Ho, V. Q. T., Fontaine, V., Anoz‐Carbonell, E., Djaout, K., Vigier, C., Faïon, L., Singh, S., Dam, S., Chatagnon, J., Slupek, S., et al. (2026) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00756-26
Electron competition in yeast mitochondria is governed by dehydrogenases catalytic efficiencies
Pinto, M. M., Pellon, C., Avéret, N., Suraniti, E., Colin, C., Ransac, S., Mazat, J., Arbault, S., Devin, A., & Rigoulet, M. (2026) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2026.149615
Metadata
- Authors
- Yano, T., Li, L.-S., Weinstein, E., Teh, J.-S., & Rubin, H.
- Affiliations
- University of Pennsylvania (US)
- Corresponding author
- Rubin, Harvey
- ORCID
- Rubin, Harvey
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-04
- Volume
- 281
- Issue
- 17
- Pages
- 11456-11463
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2040519812
- Cited by
- 150
- References
- 38
- Citations by year
- 2026: 8 · 2025: 9 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 7 · 2019: 4 · 2018: 8 · 2017: 8 · 2016: 10 · 2015: 6 · 2014: 16 · 2013: 4 · 2012: 11
- FWCI
- 4.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5296 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- University of Pennsylvania
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI043420, AI-43420)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Keywords
- Mycobacterium tuberculosis, NDH-2, phenothiazines, antitubercular agents, enzyme inhibition kinetics, ping-pong mechanism, trifluoperazine, non-competitive inhibition
- MeSH terms
- Antitubercular Agents, Binding, Competitive, Enzyme Inhibitors, Flavin-Adenine Dinucleotide, Kinetics, Mycobacterium tuberculosis, NAD, Phenothiazines, Quinone Reductases, Quinones, Ubiquinone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.